Replies to post #397738 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I am explaining it is a broad policy. If it were it you’d likely have already seen the company name mentioned in the glowing popular press coverage which has otherwise tended to focus exclusively on UCLA. You’ll see the AF’s still covering.

The policy does not apply necessarily overseas. So UK press might not be so squeamish.

Hopefully other reasons will make it impossible, like deals, to not reference the company. You will still see coverage in all the places we know already, including trading related online pubs like SeekingAlpha.

And they may find a way to quickly uplist. I am just saying what I have seen generally, I do not think it will necessarily prevent a meteoric rise in price.